Chrome Extension
WeChat Mini Program
Use on ChatGLM

Tranexamic Acid Use in Pediatric Craniotomies at a Large Tertiary Care Pediatric Hospital: A Five Year Retrospective Study

Jue T. Wang, Samir C. Seshadri, Carolyn G. Butler, Steven J. Staffa, Anna S. Kordun, Karina E. Lukovits, Susan M. Goobie

Journal of clinical medicine(2023)

Cited 0|Views20
No score
Abstract
Tranexamic acid (TXA), a synthetic antifibrinolytic drug, has proven efficacy and is recommended for major pediatric surgery to decrease perioperative blood loss. Accumulating evidence suggests that TXA reduces bleeding and transfusion in a variety of adult neurosurgical settings. However, there is a paucity of research regarding TXA indications for pediatric neurosurgery and thus, there are currently no recommendations for its use with this specific population. The objective of this study is to evaluate the existing practice of TXA administration for pediatric neurosurgery at a U.S. tertiary care pediatric hospital over a five-year period. The authors conclude that TXA administration is feasible and should be considered for pediatric neurosurgical cases where potential blood loss is a concern.
More
Translated text
Key words
pediatrics,neurosurgery,patient blood management (PBM),tranexamic acid,antifibrinolytics,blood loss
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined